Encompass Health Corporation (EHC) 股票分析

公司概述

Encompass Health Corporation operates a network of inpatient rehabilitation hospitals across the United States and Puerto Rico, delivering specialized therapeutic treatments that utilize advanced technology to assist patients recovering from major injuries or illnesses in regaining functional independence. The company functions within the healthcare sector, specifically categorized under the medical care facilities industry, positioning it as a provider of essential post-acute care services. Encompass Health Corporation currently holds a market capitalization of $10.90 billion and generates annual revenue of $5.94 billion, employing a workforce of 24,611 individuals. These valuation and revenue figures indicate a substantial market presence, reflecting the company's established footprint and significant operational scale within the specialized rehabilitation landscape.

财务健康

The company reported a trailing twelve-month revenue of $5.94 billion, accompanied by a net income of $565.70 million and an EBITDA of $1.38 billion, illustrating a revenue-to-net-income relationship where costs and taxes absorb approximately 90.5% of total sales. This gap between revenue and net income reveals a cost structure where operating expenses, including staff salaries, facility maintenance, and regulatory compliance, constitute the majority of expenditures, leaving a profit margin of 9.5%. The firm generated free cash flow of $296.79 million, which provides a measure of financial flexibility allowing for capital expenditures, debt servicing, and potential strategic investments without immediate reliance on external financing. Analyzing the margin profile, the gross margin stands at 43.2%, indicating the efficiency of the core rehabilitation services before overhead costs; the operating margin of 18.3% reflects the effectiveness of managing those overheads; and the profit margin of 9.5% represents the final bottom-line profitability after all expenses. On the balance sheet, Encompass Health Corporation holds cash of $72.20 million against total debt of $2.71 billion, resulting in a debt-to-equity ratio of 82.85, which characterizes the balance sheet as highly leveraged rather than conservative. The current ratio is recorded at 1.08, suggesting that the company's short-term liquid assets barely exceed its current liabilities, indicating a tight liquidity position that requires careful cash flow management. Additionally, the return on equity is 24.8% while the return on assets is 9.7%, metrics that reveal management is highly effective at generating shareholder value relative to equity investment, though asset utilization efficiency is moderated by the high debt load.

估值评估

The trailing twelve-month P/E ratio is 19.52, while the forward P/E is projected at 16.73, implying that the market expects earnings growth in the future that would justify a lower multiple compared to historical performance. The price-to-book ratio is 4.44, indicating that the stock trades at a significant premium over its book value, suggesting investors are pricing in intangible assets like brand reputation, patient relationships, and future growth potential. Alternative valuation metrics include a price-to-sales ratio of 1.84 and an EV/EBITDA of 10.32, which suggest the company is valued reasonably relative to its sales volume and enterprise earnings power despite the high P/E multiple. The 52-week high is $127.99 and the 52-week low is $92.77, providing a trading range context for the current valuation levels. The beta value is 0.60, indicating that the stock exhibits lower price volatility relative to the broader market, behaving as a defensive equity within the healthcare sector.

Growth & Income

Revenue growth year-over-year is 9.9%, while earnings growth year-over-year is 21.2%, demonstrating that earnings are expanding at a significantly faster rate than revenue, which implies improving operating leverage and potential cost efficiencies. Encompass Health Corporation pays a dividend with a yield of 0.7% and maintains a payout ratio of 13.0%, a low payout that is highly sustainable given the robust earnings growth and leaves ample room for retention of earnings. The low payout ratio indicates that the company prioritizes reinvesting earnings into growth initiatives rather than maximizing immediate shareholder distributions. Overall, the company presents a growth-oriented profile with modest income returns, balancing capital expansion needs with shareholder returns in a highly leveraged but profitable environment.